BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15499183)

  • 1. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity.
    Nagai J; Takano M
    Drug Metab Pharmacokinet; 2004 Jun; 19(3):159-70. PubMed ID: 15499183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy].
    Nagai J
    Yakugaku Zasshi; 2006 May; 126(5):327-35. PubMed ID: 16679740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways.
    Nagai J; Takano M
    Biochem Pharmacol; 2014 Aug; 90(4):331-7. PubMed ID: 24881578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular aspects of aminoglycoside nephrotoxicity].
    Konopska B; Warwas M
    Postepy Hig Med Dosw (Online); 2007 Sep; 61():511-8. PubMed ID: 17909519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megalin deficiency offers protection from renal aminoglycoside accumulation.
    Schmitz C; Hilpert J; Jacobsen C; Boensch C; Christensen EI; Luft FC; Willnow TE
    J Biol Chem; 2002 Jan; 277(1):618-22. PubMed ID: 11700326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
    Williams PD; Hottendorf GH; Bennett DB
    J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides.
    Williams PD; Bennett DB; Gleason CR; Hottendorf GH
    Antimicrob Agents Chemother; 1987 Apr; 31(4):570-4. PubMed ID: 3606061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
    Fillastre JP; Hemet J; Tulkens P; Morin JP; Viotte G; Olier B; Godin M
    Adv Nephrol Necker Hosp; 1983; 12():253-75. PubMed ID: 6404138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside nephrotoxicity: recent insights and perspectives.
    Tulkens PM
    Contrib Nephrol; 1984; 42():168-81. PubMed ID: 6398193
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake of aminoglycoside antibiotics into brush-border membrane vesicles and inhibition of (Na+ + K+)-ATPase activity of basolateral membrane.
    Aramaki Y; Takahashi M; Inaba A; Ishii Y; Tsuchiya S
    Biochim Biophys Acta; 1986 Nov; 862(1):111-8. PubMed ID: 3021218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of aminoglycoside antibiotics on chicken cystatin binding to renal brush-border membranes.
    Konopska B; Gburek J; Gołąb K; Warwas M
    J Pharm Pharmacol; 2013 Jul; 65(7):988-94. PubMed ID: 23738726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of megalin in renal handling of aminoglycosides.
    Nagai J; Tanaka H; Nakanishi N; Murakami T; Takano M
    Am J Physiol Renal Physiol; 2001 Aug; 281(2):F337-44. PubMed ID: 11457726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity.
    Humes HD; Weinberg JM; Knauss TC
    Am J Kidney Dis; 1982 Jul; 2(1):5-29. PubMed ID: 7048901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside-induced functional and biochemical defects in the renal cortex.
    Kaloyanides GJ
    Fundam Appl Toxicol; 1984 Dec; 4(6):930-43. PubMed ID: 6519373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs.
    Nagai J; Takano M
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1125-38. PubMed ID: 20536274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new aminoglycoside etimicin shows low nephrotoxicity and ototoxicity in zebrafish embryos.
    Shao W; Zhong D; Jiang H; Han Y; Yin Y; Li R; Qian X; Chen D; Jing L
    J Appl Toxicol; 2021 Jul; 41(7):1063-1075. PubMed ID: 33094525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside accumulation kinetics in rat renal parenchyma.
    Aronoff GR; Pottratz ST; Brier ME; Walker NE; Fineberg NS; Glant MD; Luft FC
    Antimicrob Agents Chemother; 1983 Jan; 23(1):74-8. PubMed ID: 6830211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.